News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

256,324 Results

Type

Article (13722)
Company Profile (257)
Press Release (242345)

Section

Business (79147)
Career Advice (147)
Deals (13163)
Drug Delivery (28)
Drug Development (50148)
Employer Resources (31)
FDA (5633)
Job Trends (5103)
News (143578)
Policy (10010)

Tag

Date

Today (88)
Last 7 days (406)
Last 30 days (1360)
Last 365 days (21452)
2024 (15040)
2023 (22412)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11738)
2017 (13746)
2016 (11848)
2015 (14352)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)

Filters

Type

Article (13722)
Company Profile (257)
Press Release (242345)

Section

Business (79147)
Career Advice (147)
Deals (13163)
Drug Delivery (28)
Drug Development (50148)
Employer Resources (31)
FDA (5633)
Job Trends (5103)
News (143578)
Policy (10010)

Tag

Date

Today (88)
Last 7 days (406)
Last 30 days (1360)
Last 365 days (21452)
2024 (15040)
2023 (22412)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11738)
2017 (13746)
2016 (11848)
2015 (14352)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)

256,324 Results for "vesigen therapeutics".

Sort By

Genetown

Vesigen to Present New Preclinical Data on Ophthalmology Applications of Engineered ARMMs at 2024 ARVO Annual Meeting

Vesigen Therapeutics, Inc. today announced that the Company will be presenting two posters sharing new preclinical data from its engineered ARMMs platform at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.

May 1, 2024
·
2 min read
Genetown

Vesigen to Present at the 2024 Cell and Gene Meeting on the Med

Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today announced that Paulash Mohsen, Chief Executive Officer, will present at the 2024 Cell and Gene Meeting on the Med on April 10th at 10:45 AM CET in Rome, Italy.

April 3, 2024
·
1 min read
Genetown

Vesigen Highlights Key in vivo and Targeted Tropism Data Advancements for Non-Viral Delivery Platform at 2024 ASGCT and ARVO Annual Meetings

Vesigen Therapeutics, Inc. recently showcased two data presentations at the Association for Research in Vision and Ophthalmology Annual Meeting and ten data presentations at the American Society of Gene & Cell Therapy Annual Meeting.

May 13, 2024
·
6 min read
Genetown

Vesigen to Present New Preclinical Data on Engineered ARMMs Technology at 2024 ASGCT Annual Meeting

Vesigen Therapeutics, Inc. today announced that the Company will be presenting 10 posters sharing new preclinical data from its engineered ARMMs platform at the upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting.

April 22, 2024
·
3 min read
Genetown

Vesigen Receives National Institutes of Health Award in Targeted Genome Editor Delivery Challenge

Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, was selected as a Phase 1 winner of the National Institutes of Health TARGETED Challenge.

December 19, 2023
·
2 min read
Genetown

Vesigen to Present at the 2023 Cell and Gene Meeting on the Mesa

Vesigen Therapeutics, Inc. today announced that Paulash Mohsen, Chief Executive Officer, will present at the 2023 Cell and Gene Meeting on the Mesa on October 12 at 9:15 AM PT in Carlsbad, CA.

October 5, 2023
·
1 min read
Genetown

Vesigen Highlights New Data on Non-Viral Delivery Platform at the Exosome Based Therapeutic Development Summit

Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today showcased new data at the Exosome Based Therapeutic Development Summit 5th Annual Meeting held September 5-7, 2023 in Boston.

September 7, 2023
·
1 min read
Genetown

Vesigen Highlights Non-Human Primate Biodistribution of Non-Viral Technology and Functional Delivery of Genome Editors In Vivo at the Cracking the Code: The Dawn of Nucleic Acid Medicines Meeting

Vesigen Therapeutics, Inc. presented data further highlighting the potential of the Company’s non-viral ARMM technology to deliver novel therapeutic payloads to cell and tissue types relevant to multiple therapeutic areas with high unmet need.

October 19, 2023
·
3 min read
Genetown

Vesigen Highlights Data Demonstrating Directed Tropism of Non-Viral Delivery Platform at the 30th Annual Congress of the European Society of Gene & Cell Therapy

Vesigen Therapeutics, Inc. today presented data highlighting the potential of the Company’s non-viral ARMM (ARrestin-domain 1 Mediated Microvesicles) technology to overcome fundamental delivery challenges that limit the clinical application of emerging treatment modalities.

October 25, 2023
·
3 min read
Genetown

Vesigen Highlights Therapeutic Platform for Non-Viral Delivery of Gene Editors and RNA at ASGCT 2023

Vesigen Therapeutics, Inc showcased eight data presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting held May 16-20, 2023 in Los Angeles.

May 22, 2023
·
4 min read

1 of 25,633

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin